CD300LF Activators
Chemical activators of CD300LF, a protein involved in immune regulation, exert their effects through diverse biochemical mechanisms, indirectly augmenting the protein's functional activity. Resolvin D1 facilitates anti-inflammatory signaling, enhancing CD300LF's role in resolving inflammation by acting on receptors that CD300LF-expressing immune cells may express. Lithium chloride's influence on the PI3K/Akt/GSK-3β pathway indirectly stabilizes the immune cell environment, which can contribute to CD300LF's regulatory activities. Spermidine promotes autophagy, aiding the immune surveillance functions of CD300LF, while Piceatannol's inhibition of Syk kinase could lead to an upregulated immune response mediated by CD300LF. PD 98059 and U0126, both modulating the MAPK/ERK pathway, and SB 203580, targeting p38 MAPK, alter cytokine profiles and immune cell stress responses, thus enhancing CD300LF's regulatory roles.
Moreover, Forskolin, by elevating intracellular cAMP levels, and Rolipram, through inhibition of phosphodiesterase-4, both increase PKA activity, which may further potentiate CD300LF's function in immune cell signaling. CP-690550 (Tofacitinib), a Janus kinase inhibitor, and LY294002, a PI3K inhibitor, recalibrate cytokine signaling and immune cell function, which could indirectly lead to an enhanced activity of CD300LF in immune response moderation. Dexamethasone, a glucocorticoid, modulates inflammatory pathways to amplify CD300LF's anti-inflammatory effects. Collectively, these chemical compounds, by targeting specific signaling pathways, contribute to the fine-tuning of CD300LF's role in immune cell regulation without directly increasing its expression or activity, thereby reinforcing the protein's role in the immune system's balance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resolvin D1 | 872993-05-0 | sc-204877 sc-204877A | 10 µg 25 µg | $262.00 $614.00 | 1 | |
Resolvin D1, found in docosahexaenoic acid (DHA), is involved in the resolution phase of inflammation. It binds to G-protein-coupled receptors, which may include those on immune cells expressing CD300LF, leading to the inhibition of inflammatory processes and thereby enhancing the anti-inflammatory function of CD300LF. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride influences the PI3K/Akt/GSK-3β pathway. Akt activation leads to the phosphorylation and inactivation of GSK-3β, a kinase that can phosphorylate proteins associated with immune response. CD300LF, involved in immune cell regulation, may have enhanced activity due to the stabilization of the cellular environment by lithium's action. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine, a polyamine, is involved in autophagy modulation and cell growth. Through the enhancement of autophagy, spermidine could support the removal of cellular debris and pathogens, a process in which CD300LF is potentially implicated, thereby indirectly enhancing the functional activity of CD300LF in immune surveillance. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol inhibits the Syk kinase, a key component of immunoreceptor signaling. By modulating the activity of Syk, piceatannol can alter signaling pathways in immune cells, possibly leading to an enhanced function of CD300LF in mediating immune cell responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a MEK inhibitor that interferes with the MAPK/ERK pathway. Inhibition of this pathway can result in altered signaling in immune cells. Since CD300LF is an immune receptor, this modulation can indirectly enhance the activation state of CD300LF by affecting downstream signaling cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that can change the cytokine profile and stress response of immune cells. By inhibiting p38 MAPK, it could shift the immune response in a way that enhances the regulatory functions of CD300LF, such as modulating the inflammatory response. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP can potentiate anti-inflammatory pathways within immune cells, which may enhance the activity of CD300LF as it plays a role in immune cell signaling and regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that affects the survival and function of immune cells. By inhibiting PI3K, it can modulate the activity of immune cells, possibly leading to an increased functional role of CD300LF in regulating immune responses. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a phosphodiesterase-4 inhibitor, leading to increased cAMP levels in immune cells. The resultant activation of PKA can influence signaling pathways in which CD300LF may be involved, therefore potentially enhancing the immune regulatory functions of CD300LF. | ||||||